xRead Articles - October 2022

59. Khalid S, Murdoch R, Newlands A, et al. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. J Allergy Clin Immunol 2014; 134:56 – 62. 60. Patel AS, Watkin G, Willig B, et al. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chron Respir Dis 2011;8:253 – 258. 61. Ryan NM, Vertigan AE, Bone S, Gibson PG. Cough re fl ex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 2010;6:5. 62. Smith JA, Kitt MM, Butera P, et al. Gefapixant in two randomised dose escalation studies in chronic cough. Eur Respir J 2020;55:1901615. 63. Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ. A cohort description and analysis of the effect of gabapentin on idiopathic cough. Cough 2012;8:9. 64. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Ef fi cacy of speech pathology management for chronic cough: a randomised placebo con trolled trial of treatment ef fi cacy. Thorax 2006;61:1065 – 1069. 65. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Develop ment of a symptom speci fi c health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58:339 – 343. 66. Shembel AC, Rosen CA, Zullo TG, Gartner-Schmidt JL. Development and validation of the cough severity index: a severity index for chronic cough related to the upper airway. Laryngoscope 2013;123:1931 – 1936.

67. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough speci fi c quality-of-life questionnaire. Chest 2002;121:1123 – 1131. 68. Kempster GB, Gerratt BR, Verdolini Abbott K, Barkmeier-Kraemer J, Hillman RE. Consensus auditory-perceptual evaluation of voice: develop ment of a standardized clinical protocol. Am J Speech Lang Pathol 2009; 18:124 – 132. 69. Johnson A, Jacobson B, Grywalski C, Silbergleit A, Jacobson G, Benninger M. The voice handicap index (VHI): development and valida tion. Am J Speech Lang Pathol 1997;6:66 – 70. 70. Raj AA, Pavord DI, Birring SS. Clinical cough IV:what is the minimal important difference for the Leicester cough questionnaire? Handb Exp Pharmacol 2009;187:311 – 320. 71. Morice AH, Jakes AD, Faruqi S, et al. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 2014; 44:1149 – 1155. 72. Kavalcikova-Bogdanova N, Kovacikova L, Buday T, et al. Sensitivity of air way cough-related afferents is in fl uenced by female sex hormones. Respir Physiol Neurobiol 2018;257:12 – 17. 73. Morice AH, McGarvey L, Pavord I. British Thoracic Society cough guideline recommendations for the management of cough in adults. Thorax 2006; 61:i1 – i24. 74. Bradley JP, Gross J, Paniello RC. Superior laryngeal nerve tran section for neuropathic cough: a pilot study. Auris Nasus Larynx 2020;47:837 – 841.

Laryngoscope 132: January 2022

Wamkpah et al.: Multimodal Treatments for Neurogenic Cough 123

Made with FlippingBook - Online Brochure Maker